RUSSO, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 4.029
AS - Asia 3.370
EU - Europa 3.106
SA - Sud America 1.036
AF - Africa 90
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 11.651
Nazione #
US - Stati Uniti d'America 3.924
SG - Singapore 1.872
BR - Brasile 907
IE - Irlanda 771
CN - Cina 697
IT - Italia 654
SE - Svezia 482
HK - Hong Kong 361
DE - Germania 285
PL - Polonia 217
FI - Finlandia 195
VN - Vietnam 145
RU - Federazione Russa 108
FR - Francia 102
IN - India 96
GB - Regno Unito 84
UA - Ucraina 76
AR - Argentina 45
CA - Canada 41
MX - Messico 40
EC - Ecuador 29
TR - Turchia 28
BD - Bangladesh 25
BE - Belgio 25
ZA - Sudafrica 25
CI - Costa d'Avorio 22
NL - Olanda 22
JP - Giappone 21
AT - Austria 20
ID - Indonesia 19
MA - Marocco 17
IQ - Iraq 16
ES - Italia 15
UZ - Uzbekistan 15
CO - Colombia 13
VE - Venezuela 12
LT - Lituania 11
AZ - Azerbaigian 10
CL - Cile 10
CZ - Repubblica Ceca 9
KE - Kenya 9
PK - Pakistan 9
PY - Paraguay 9
AU - Australia 8
EU - Europa 8
TN - Tunisia 7
HN - Honduras 6
NP - Nepal 6
JO - Giordania 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
JM - Giamaica 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
BH - Bahrain 3
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GR - Grecia 3
IR - Iran 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
OM - Oman 3
RS - Serbia 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
DM - Dominica 2
GA - Gabon 2
KR - Corea 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
DZ - Algeria 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
TG - Togo 1
TV - Tuvalu 1
Totale 11.649
Città #
Dublin 768
Chandler 562
Ashburn 548
Singapore 522
Dallas 516
Hong Kong 361
Nyköping 324
Beijing 318
Warsaw 214
Messina 202
Jacksonville 187
Munich 157
Princeton 132
Ann Arbor 121
Medford 114
Los Angeles 110
Helsinki 81
Des Moines 79
São Paulo 74
The Dalles 73
Cambridge 72
Dearborn 67
New York 60
Ho Chi Minh City 57
Buffalo 55
Moscow 50
Boardman 46
Bremen 41
Wilmington 39
Redondo Beach 38
Tianjin 36
Turku 35
Jinan 32
Pune 31
Rio de Janeiro 30
Houston 23
Hyderabad 23
Abidjan 22
Shenyang 22
Brussels 21
Curitiba 21
Catania 20
Seattle 20
Hanoi 19
Santa Clara 19
Rome 18
Belo Horizonte 17
Brooklyn 17
Council Bluffs 17
Nanjing 17
Tokyo 17
Zhengzhou 17
Brasília 16
Nuremberg 16
Woodbridge 16
Hebei 15
Johannesburg 15
Mexico City 15
Ningbo 15
San Mateo 15
Campinas 14
Chennai 14
London 14
Tashkent 14
Chicago 13
Frankfurt am Main 13
Lappeenranta 13
Denver 12
Dong Ket 12
Duncan 12
Jakarta 12
Lancaster 12
Montreal 12
Taizhou 12
Changsha 11
Porto Alegre 11
Baku 10
Haikou 10
Hangzhou 10
Milan 10
Poplar 10
Quito 10
Redwood City 10
Salvador 10
San Francisco 10
Amsterdam 9
Atlanta 9
Falls Church 9
Guayaquil 9
Joinville 9
Nairobi 9
Palermo 9
Ribeirão Preto 9
Sorocaba 9
Ankara 8
Boston 8
Duque de Caxias 8
Phoenix 8
Toronto 8
Vienna 8
Totale 7.025
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 300
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 254
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 232
Clinical and pathological features of focal myositis 225
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 219
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 217
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 217
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 170
A Nouvel serum MicroRNA signature to screen ATTR 160
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 152
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 151
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 150
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 141
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 138
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 128
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 126
Alexithymia, burden and resilience in ALS’ caregivers 126
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 126
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 125
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 123
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 117
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron 116
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 116
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 115
Autoimmune juvenile limb-girdle myasthenia 115
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 115
La deformazione longitudinale e radiale del ventricolo sinistro è ridotta nell’amiloidosi cardiaca familiare: studio con ecocardiogramma bi-dimensionale e risonanza magnetica cardiaca. 113
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 112
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 112
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 111
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 110
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 109
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 108
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 107
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 105
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 103
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 102
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 101
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 100
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 99
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 98
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 98
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 97
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 95
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 95
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 94
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 94
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 93
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 93
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 93
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy 92
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 92
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy 90
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 86
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 85
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 85
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 85
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 84
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 84
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 83
Miopatia prossimale in paziente con sindrome di Williams 82
Considerable post-partum worsening in a patient with CMT2E 82
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 80
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 80
Factors predicting survival in ALS: a multicenter Italian study 79
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 78
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy 77
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 75
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 75
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury 75
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 73
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). 72
The THAOS: record of patients from our site. 70
Prominent distal lower limbs involvement with hyperreflexia in a family with seipin related axonal motorneuropathy. 68
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 68
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: Secondary analysis of data from the CI-PeriNomS study 66
Variable phenotypes are associated with PM22 missense mutations. 66
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 66
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 65
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 64
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 63
Nuclear factor-kappaB, mitogen-activated protein kinases and cyclooxygenase/5-lipoxygenase pathway inhibition by flavocoxid improves muscle function and morphology in mdx mice: a comparison study with methylprednisolone. 63
Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: the effect of male sex on survival of C9orf72 positive patients. 63
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 63
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 63
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 62
Correlation between morphologic and functional echocardiographic indexes and semiquantitative analysis of 99mTC-DPD scintigraphy in patients with transthyretin related amyloidosis 62
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 62
Correlation between clinical, biochemical indexes and semiquantitative analysis of 99mTc-DPD scintigraphy in patients with transthyretin related amyloidosis 61
COLD PAINFUL NEUROPATHY: A PECULIAR PHENOTYPE OF NEUROPATHIC PAIN 61
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 61
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 61
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 60
Left atrial function in cardiac amyloidosis 60
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 60
The role of metacognitive beliefs on anxiety and depression among Amyotrophic Lateral Sclerosis caregivers 59
Corneal Sub-Basal Nerve Plexus in Non-Diabetic Small Fiber Polyneuropathies and the Diagnostic Role of In Vivo Corneal Confocal Microscopy 58
Gene expression profile in transthyretin related familial amyloidotic polyneuropathy 58
Systematic investigation on needs and use of technological device in amyotrophic lateral sclerosis patients and caregivers: a natinwide, multicentre survey. 58
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy 58
Totale 10.159
Categoria #
all - tutte 46.168
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.168


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 60 49 34 42 95 39 29
2021/2022776 19 90 5 30 51 11 75 42 26 50 59 318
2022/20232.091 171 189 113 155 161 174 21 95 938 7 46 21
2023/2024536 45 80 26 39 56 127 20 32 7 36 15 53
2024/20253.662 46 52 65 181 149 129 186 576 668 170 658 782
2025/20262.937 410 619 601 545 708 54 0 0 0 0 0 0
Totale 12.053